top of page

The patient is first examined for DNA from the tumor tissue (or pre-operative blood sample), and the DNA mutations found are subsequently repeatedly screened in the patient's plasma.

 

If a DNA mutation is detected in the blood, the patient is immediately recommended for further testing to confirm the diagnosis. Subsequent treatment is already done within the standard cancer care system.

How oncoMonitor™ test works step by step:

ask-question_edited.png
clovek-2pt_edited.png
cancer-ribbon.gif
macbook_edited_edited.png
info-red.png
arrow2.gif

1. The patient will receive initial information from their attending physician or on our website or contact us via the online form. Upon receipt, we will evaluate it and contact the patient immediately about the appropriateness of using the oncoMonitor test.

2. The attending physician will provide detailed information to the patient and explain the whole issue. The availability of tumor tissue samples is determined, pricing is proposed, and the patient signs the approval of the examination.

3. Blood samples are collected from the patient and the blood plasma is subsequently examined for the presence of DNA mutations.

4. The test results are evaluated and sent to the attending physician who will decide about further steps. The test results are always available within 14 days of the patient's blood collection.

5. The design of regular intervals for further blood sampling is created for the best use of the obtained results. Usually, the following blood collections are at 3-month time intervals, so a total of 4 blood samples are examined for one year. 

arrow2.gif
clovek-2pt_edited.png
cancer-ribbon.gif
agreement-red.png
clovek-2pt_edited.png
cross.png
stethoscope-red.png
arrow2.gif
arrow2.gif
strikacka.gif
drop-of-blood.gif
clovek-2pt_edited.png
cancer-ribbon.gif
search-in-browser_edited_edited.png
biotech-dna-red.gif
ecg-red.gif
strevo.gif
arrow2.gif
search-text_edited_edited_edited.png
arrow2.gif
tick-green.gif
tick-green.gif
close-red.gif
clovek-2pt_edited.png
cross.png
stethoscope-red.png
tube-full-s-dna-white_grey2.gif
tube-full-s-dna-white_grey2.gif
tube-full-s-dna-white_grey2.gif
tube-full-s-dna-white_grey2.gif

Reimbursement for oncoMonitor

OncoMonitor is currently not covered by health insurance companies in the Czech Republic.

It is a completely unique and above-standard service, the patient is a self-payer.

Questionnaire: Is oncoMonitor appropriate for you?
1) Have you been diagnosed with colorectal cancer?
2) Has your tumor been diagnosed in an advanced stage of the disease, i.e. the presence of distant metastases (metastases in other organs) has been detected?
3) Was it a distant metastasis in the liver or lungs?
4) Have you subsequently undergone a surgery and the liver/lungs metastasis has been removed or is such a surgery currently planned for you?
5) Are you now being followed by an oncologist or other attending specialist (surgeon, gastroenterologist, etc.) and are you being monitored by imaging methods (CT, ultrasonography, magnetic resonance, etc.), or such a post-operative follow-up is planned for you with your attending physician in the case the surgical removal is not yet done?

Thank you for completing your questionnaire!

Questionnaire
bottom of page